ArticleJournal of clinical hypertension (Greenwich, Conn.)2019
Mineralocorticoid antagonists and ENaC inhibitors in hyperaldosteronism.
Michael A Hill et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it